Nonprofit seeks to dispel ‘myths’ about how it assesses drug values
(By Ed Silverman for STAT) In the face of growing criticism over its efforts to place a value on new
Read More
Part D/Prescription Drugs
US babies born addicted to opioids has tripled in 15 years, CDC says
(By Casey Ross for STAT) The number of babies being born in the United States addicted to opioids has tripled
Read MoreImprecise research threatens precision medicine
(By Spencer Phillips Hey and Aaron S. Kesselheim for STAT) The right treatment for the right patient at the right
Read MoreIRS is urged to investigate Gilead for ‘dodging’ US taxes
(By Ed Silverman for STAT) An advocacy group is urging the US Internal Revenue Service and the US Treasury Department
Read MoreInsurance Rules Can Hamper Recovery From Opioid Addiction
(By Jake Harper, Side Effects Public Media, for Kaiser Health News) Twice a day, Angela and Nate Turner of Greenwood,
Read MoreThe Future of Drug Pricing
Could global pressure on health spending force the pharmaceutical industry to embrace pricing drugs based on clinical outcomes instead of
Read MoreSeniors Can Lower Their Medicare Drug Costs
Do you know the seven strategies to consider that could help lower your Medicare prescription drug costs such as: stay
Read MoreThe race for a Zika vaccine is intense. But it may be missing the most important players
(By Helen Branswell for STAT) About a year ago, before the Zika virus grabbed global attention, there were zero vaccines
Read MoreAbbVie and Amgen lock horns in the latest squabble over biosimilars
(By Ed Silverman for STAT) In the latest contest over biosimilars, AbbVie has filed a patent infringement lawsuit against Amgen,
Read MorePfizer closes plant in India after several regulators find problems
(By Ed Silverman for STAT) More than a year after spending roughly $17 billion to acquire Hospira, Pfizer is finding
Read More